Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
Cytokinetics’ $540 Million Convertible Senior Notes Offering
Cribl’s $150 Million Series D Funding
Cooley advised Cribl on the deal. Cribl, a leader in enabling open observability for technology professionals, announced its $150 million Series D financing round. In connection with...